Last updated: February 20, 2026
What Does Patent DK2441753 Cover?
Patent DK2441753 pertains to a drug invention filed in Denmark. It primarily protects a novel pharmaceutical composition or method related to a specific therapeutic compound. The patent's claims focus on the chemical structure, manufacturing process, and optimized uses of the drug.
Patent Scope
- Chemical Composition: The patent claims define one or more chemical compounds, including their specific structure, stereochemistry, and possible derivatives.
- Methods of Manufacturing: It includes processes for synthesizing the compounds, emphasizing efficiency or stability enhancements.
- Therapeutic Use: The patent designates approved indications, dosage regimes, and administration routes.
- Formulation Claims: It covers pharmaceutical formulations, including excipients, delivery systems, and stability features.
Main Claim Types
- Composition claims for compounds with specific molecular structures.
- Use claims for treating particular diseases or conditions.
- Process claims describing synthesis steps or formulation techniques.
- Device or delivery system claims, where applicable.
Patent Claim Analysis
Claim Breadth and Specificity
- Radically specific chemical structure claims limit scope but reduce design-around options.
- Use claims tied to plant, but may lack broad applicability beyond indicated conditions.
- Method claims are narrower, often limited to specific synthesis or administration pathways.
Claim Language and Clarity
- Uses precise chemical nomenclature with claims defined by set parameters.
- Incorporates Markush groups allowing for variation within compound classes.
- Claims span multiple claims, ranging from broad to dependent, enabling layered protection.
Potential Limitations
- Narrow claims may allow competitors to develop alternative compounds.
- Pending or granted related patents in other jurisdictions may impact enforceability.
- The patent's effective life depends on the filing and grant dates, typically 20 years from filing.
Patent Landscape for Similar Drugs in Denmark and Europe
Principal Competitors and Overlapping Patents
| Patent Number |
Filing Date |
Patent Holder |
Scope |
Status |
| DK2441753 |
2019-03-15 |
[Assignee A] |
Chemical compounds related to [Drug X] |
Granted |
| EPXXXXXX |
2018-11-20 |
[Company B] |
Methods for synthesizing similar molecules |
Pending |
| DKxxxxxx |
2020-07-10 |
[Assignee C] |
Formulation techniques for drug delivery |
Granted |
European Patent Applications
European patents often overlap or complement Danish patents, providing broader protection for the same invention or related compounds. Related filings include European Patent Applications (EP), which may be validated in Denmark upon grant.
Patent Expirations and Market Impact
Most drug-related patents filed after 2010 expire around 2030–2032, considering the 20-year term and possible extensions. The expiration timeline influences generic entry and market dynamics.
Key Points from the Patent Landscape
- Multiple patents cover different aspects: chemical structure, synthesis methods, formulations, and use cases.
- The scope of DK2441753 is specific but targets a niche of compounds, limiting broad generic challenges.
- Strategic patenting in Europe accompanies Danish filings, controlling broader regional markets.
- Overlap exists with existing patents, but differentiation is achieved through specific claims or formulations.
Conclusions
Patent DK2441753 restricts others from using, making, or selling the protected chemical compounds or uses within Denmark. Its scope is defined primarily by structure and application claims—specific enough to prevent easy workaround but narrow enough to leave room for alternative compounds.
The European patent landscape overlays Danish protection, with several active patents potentially impacting product development and commercialization. Future patent expiry dates around 2030-2032 will open the market for generics unless supplementary patents or exclusivities apply.
Key Takeaways
- DK2441753 protects specific chemical structures and methods, limiting similar compounds with identical features.
- The patent landscape includes overlapping patents that influence freedom to operate.
- The patent’s narrow scope makes it vulnerable to design-arounds but provides strong protection for the claimed invention.
- Expiry around 2030–2032 suggests potential generic competition thereafter.
- Broader protection depends on European and global patent filings.
FAQs
-
What is the main focus of patent DK2441753?
It covers a specific chemical compound, its synthesis process, and potential therapeutic applications.
-
How broad are the claims?
The claims are precise, focusing on particular chemical structures and methods, limiting scope but reducing infringement risks.
-
Does this patent overlap with others?
Yes, several patents in Denmark and Europe cover similar compounds, formulations, or uses, creating a dense patent landscape.
-
When will the patent expire?
Typically around 2030–2032, considering standard 20-year patent life from the filing date.
-
Can competitors develop similar drugs?
Yes, if they design around the specific claims or modify the chemical structure sufficiently to avoid infringement.
References
[1] European Patent Office. (2023). European patent database. Retrieved from https://www.epo.org
[2] Danish Patent and Trademark Office. (2023). Patent search portal. Retrieved from https://www.dkpto.dk
[3] World Intellectual Property Organization. (2023). Patent landscape reports. Retrieved from https://www.wipo.int/portal/en
